| Mrs Arlene Klein Unger, PHD | |
|
34231 Camino Capistrano, #213, Dana Point, CA 92624-1156 | |
| (949) 240-7302 | |
| (949) 218-7609 |
| Full Name | Mrs Arlene Klein Unger |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 34231 Camino Capistrano, Dana Point, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508961863 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY 15383 (California) | Primary |
| Entity Name | Grow Healthcare Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154994846 PECOS PAC ID: 1850774746 Enrollment ID: O20220809004080 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today presented additional interim data from its ongoing Phase I trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement. The data were presented at the Chemotherapy Foundation Symposium being held in New York City.
ChanTest, the leading CRO expert in ion channels and nonclinical cardiac safety testing, announces funding of a Phase II SBIR grant. ChanTest will use the grant from the National Heart Lung & Blood Institute to optimize drug safety and discovery assays using stem cell-derived human cardiomyocytes
Ipsen a global biopharmaceutical group, today announced that its partner Roche disclosed results of five Phase III 24-week studies for taspoglutide for type 2 diabetes at the American Diabetes Association's (ADA) 70th Annual Scientific Sessions. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
A new study by researchers at Children's Hospital Los Angeles has shown that tissue-engineered small intestine grown from human cells replicates key aspects of a functioning human intestine. The tissue-engineered small intestine they developed contains important elements of the mucosal lining and support structures, including the ability to absorb sugars, and even tiny or ultra-structural components like cellular connections.
The International AIDS Society (IAS) announced today the six winners of three prestigious scientific awards, to be presented at plenary sessions during the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention to be held in Rome July 17-20, 2011.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Arlene Klein Unger, PHD 34300 Lantern Bay Dr, #29, Dana Point, CA 92629-2874 Ph: (949) 240-7302 | Mrs Arlene Klein Unger, PHD 34231 Camino Capistrano, #213, Dana Point, CA 92624-1156 Ph: (949) 240-7302 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today presented additional interim data from its ongoing Phase I trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement. The data were presented at the Chemotherapy Foundation Symposium being held in New York City.
ChanTest, the leading CRO expert in ion channels and nonclinical cardiac safety testing, announces funding of a Phase II SBIR grant. ChanTest will use the grant from the National Heart Lung & Blood Institute to optimize drug safety and discovery assays using stem cell-derived human cardiomyocytes
Ipsen a global biopharmaceutical group, today announced that its partner Roche disclosed results of five Phase III 24-week studies for taspoglutide for type 2 diabetes at the American Diabetes Association's (ADA) 70th Annual Scientific Sessions. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
A new study by researchers at Children's Hospital Los Angeles has shown that tissue-engineered small intestine grown from human cells replicates key aspects of a functioning human intestine. The tissue-engineered small intestine they developed contains important elements of the mucosal lining and support structures, including the ability to absorb sugars, and even tiny or ultra-structural components like cellular connections.
The International AIDS Society (IAS) announced today the six winners of three prestigious scientific awards, to be presented at plenary sessions during the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention to be held in Rome July 17-20, 2011.
› Verified 2 days ago
Dr. Suzanne Ruth Engelman, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 25 Gavina, Dana Point, CA 92629 Phone: 949-460-4908 Fax: 949-248-0421 | |
Dr. Eileen M Kramer, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 24681 La Plz Ste 370, Dana Point, CA 92629 Phone: 949-899-5790 Fax: 224-365-3488 | |
Dr. Colleen Masters, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 28 Monarch Bay Plaza, Suite N, Dana Point, CA 92629 Phone: 949-489-8005 | |
Dr. Maha Nasrallah-babenko, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 33442 Valley View Ct, Dana Point, CA 92629 Phone: 949-201-6421 | |
Dr. Helene A O'mahony, PH.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 34 Brigeport, Dana Point, CA 92629 Phone: 310-871-6419 | |
Dr. Deborah Robin Winograd, PHD Psychologist Medicare: May Accept Medicare Assignments Practice Location: 34091 Calle La Primavera Unit B, Dana Point, CA 92629 Phone: 916-254-8982 |